ClinicalTrials.gg
CompletedNCT06805331Updated Oct 6, 2026

The Effect of Health Belief Model-Based Pelvic Floor Muscle Exercise Training on Urinary Incontinence and Quality of Life in Female Patients With Multiple Sclerosis

An interventional study of Intervention group(Pelvic Floor Muscle Exercise Training) and control group in Multiple Sclerosis and Urinary Incontinence, sponsored by Nurgül KAPLAN. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Nurgül KAPLAN · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jul 2024, registered Jan 2025).
Updated Oct 6, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 309 studies in Multiple Sclerosis with a site in Turkey — 60 open to participants now, 79 under way, 10 of them phase 3. Multiple Sclerosis · Turkey.

Enrollment
88th of 206
46 · median 40
Started
2024
with 24 others
No phase
157 of 309
32 open now
Registered
216th of 309
by date

Among the 309 studies in Multiple Sclerosis with a site in Turkey, this one is the 88th largest by enrollment of the 206 interventional ones that give a count, is one of 25 that started in 2024, is one of 157 with no phase, and was the 216th registered.

Multiple Sclerosis

3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

60 of the 309 studies in Multiple Sclerosis with a site in Turkey are open now. Recruiting first, the newest first:

55 more — sign in →

All 60 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 309 studies in Multiple Sclerosis with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effect of Pelvic Floor Muscle Exercise Training According to the Health Belief Model on Urinary Incontinence and Quality of Life in Female Patients with Multiple Sclerosis.

Hypothesis 01: Pelvic floor muscle exercise training applied using the health belief model is not effective in reducing urinary complaints in female MS patients.

Hypothesis 1: Pelvic floor muscle exercise training applied using the health belief model is effective in reducing urinary complaints in female MS patients.

Hypothesis 02: Pelvic floor muscle exercise training applied using the health belief model is not effective on the quality of life of female MS patients.

Hypothesis 2: Pelvic floor muscle exercise training applied using the health belief model is effective on the quality of life of female MS patients.

Read the detailed description

This study will be conducted to evaluate the effect of pelvic floor muscle exercise (PFMT) training on urinary incontinence and quality of life in women with multiple sclerosis (MS) according to the health belief model (HBM). This study will be conducted as a randomized controlled experimental study with 46 women with urinary incontinence complaints who were diagnosed with MS and followed up at the MS outpatient clinic of the Neurology Department of Tokat Gaziosmanpaşa University Hospital. Patients will be included in the control (23) and intervention (23) groups by simple randomization method. In collecting the research data; Questionnaire on Descriptive Characteristics, International Incontinence Questionnaire Short Form (ICIQ-SF), Incontinence Quality of Life Scale (I-QOL), Incontinence Severity Index (ISI), Broome Pelvic Floor Muscle Exercise Self-Efficacy Scale (Broome PMSES), Expanded Disability Status Scale (EDSS), Bladder diary will be used. The research data will be collected after the experimental and control groups are determined after the approval. Data collection forms will be applied to both groups at the beginning of the study and at the end of the 1st and 3rd months. Patients in the intervention group will perform pelvic floor muscle exercises 3 times a day (morning-afternoon-evening) for 3 months. No intervention will be applied to patients in the control group. The data will be entered into a statistical package program and evaluated. No study has been found in the literature evaluating the effect of PTCE training according to the SIM on urinary incontinence and quality of life in female patients with MS. The research has original value in this respect and will contribute scientifically to national and international literature. If the research is successful, it is thought that PTCE training according to the health belief model in female patients with MS will be proven as a non-pharmacological intervention and will provide a new nursing intervention in the field. PTCE training according to the SIM in female patients with MS will reduce urinary incontinence and increase quality of life. In addition, it is thought that it will contribute positively to the physiological, psychological and social recovery process of MS patients.

03

Conditions studied

  • Multiple Sclerosis
  • Urinary Incontinence

Keywords

  • Exercise training
  • Multiple Sclerosis
  • Pelvic Floor Muscle Exercise
  • Health Belief Model
  • Urinary Incontinence
  • Quality of Life
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years old and above,
  • Being a woman,
  • Being diagnosed with MS,
  • Having urinary incontinence,
  • Not having an attack in the last thirty days,
  • No change in medical treatment in the last three months,
  • Being under 6.5 on the Expanded Disability Status Scale (EDSS),
  • Not having a diagnosis of cognitive or mental disorder,
  • Being willing to participate in the study,

Exclusion criteria

Exclusion Criteria:

  • Presence of pregnancy,
  • Presence of urinary tract infection,
  • Presence of another neurological disease that may cause incontinence,
  • History of cancer,
  • History of pelvic surgery,
  • Presence of pelvic organ prolapse,
  • Deficiency in evaluation parameters,
  • Non-compliance with treatment programs,
  • Change in drug treatment during treatment,
  • Receiving PTCE in the last six months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Intervention Group (Pelvic Floor Muscle Exercise Training)

    The researcher will explain pelvic floor muscle exercises to the patients within the framework of the health belief model. After the pelvic floor muscle exercise training is given, the patients will be asked to do these exercises three times a day (morning-afternoon-evening) for three months (12 weeks).

    Behavioral: Intervention group(Pelvic Floor Muscle Exercise Training)

  • Other
    No Intervention (Control Group)

    Participants in the control group will undergo standard care procedures without receiving any intervention. The results will be evaluated for comparison purposes.

    Other: control group

Interventions

  • BehavioralIntervention group(Pelvic Floor Muscle Exercise Training)

    The intervention will involve educating participants on pelvic floor muscle exercises, using the health belief model. The goal is to evaluate improvements in incontinence severity, quality of life, and pelvic floor muscle exercise self-efficacy

  • Othercontrol group

    Participants in the control group will continue to receive their current standard of care and will not receive any additional interventions.

06

What researchers measure

Primary outcomes

  1. Urinary Incontinence

    Urinary incontinence severity and impact will be assessed at baseline and after 3 months using the International Incontinence Questionnaire Short Form (ICIQ-SF).

    Time frame: Three months

Secondary outcomes

  1. Quality of life in Women with Multiple Sclerosis

    The impact of incontinence on quality of life will be assessed at baseline and after 3 months using the Incontinence Quality of Life Scale (I-QOL).

    Time frame: Three months

Other outcomes

  1. The Broome Pelvic Floor Muscle Exercise Self-Efficacy

    Individuals' self-efficacy beliefs regarding performing pelvic floor muscle exercises will be assessed using the Broome Pelvic Floor Muscle Exercise Self-Efficacy Scale at baseline and after 3 months.

    Time frame: Three months

07

Study locations

1 site
  • Tokat Gaziosmanpaşa University
    Tokat Province, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Clinical study report

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Dec 2024, 5 months.

Of 852 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's 5 months is below that.

Counting every sponsor, half of 874 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Apr 2025 → Jul 2024, primary completion Jun 2025 → Dec 2024 and completion Jun 2025 → Dec 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2025
First posted
Feb 3, 2025
StartActual
Jul 1, 2024was Apr 2025
Primary completionActual
Dec 1, 2024was Jun 2025
CompletionActual
Dec 31, 2024was Jun 2025
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Apr 9, 2025→Jul 1, 2024
Oct 6, 2026
Primary completion
Jun 1, 2025→Dec 1, 2024
Oct 6, 2026
Study completion
Jun 13, 2025→Dec 31, 2024
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Start date Apr 9, 2025→Jul 1, 2024
    Primary completion Jun 1, 2025→Dec 1, 2024
    Study completion Jun 13, 2025→Dec 31, 2024
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06805331
Lead sponsor
Nurgül KAPLAN
Responsible party
Nurgül KAPLAN (Instructor, Tokat Gaziosmanpasa University) — Sponsor-investigator
First posted
Feb 3, 2025
Start date
Jul 1, 2024
Primary completion
Dec 1, 2024
Completion
Dec 31, 2024
Last update
Oct 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion